BUDAPEST, Hungary and SANTA CLARA, California, September 21 /PRNewswire/-- ChemAxon, a software solutions provider for cheminformatics, and AgilentTechnologies Inc. (NYSE: A) today announced an agreement to maintain theintegration between the Kalabie Electronic Laboratory Notebook (ELN) andChemAxon's software suite. Agilent acquired the Kalabie ELN from Klee in June2007. The contract transitions existing agreements between Klee and ChemAxonto Agilent and ChemAxon.
"We are very pleased to be working with Agilent, as our cheminformaticstoolkits are particularly relevant to their current and future strategy,"said Ferenc Csizmadia, CEO of ChemAxon.
"Kalabie's unique open design allows easy and effective integration tochemistry cartridge technologies," said Alain Meller, Agilent's ELN director."The integration with ChemAxon's JChem offers an integrated solution that isseamless in software and services."
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurementcompany and a technology leader in communications, electronics, life sciencesand chemical analysis. The company's 19,000 employees serve customers in morethan 110 countries. Agilent had net revenue of $5.0 billion in fiscal year2006. Information about Agilent is available on the Web athttp://www.agilent.com.
ChemAxon is a leader in providing cheminformatics software developmentplatforms and applications for the biotechnology, pharmaceutical andagrochemical industries. With core capabilities for structure visualization,search and management, property prediction, virtual synthesis, screening anddrug design, ChemAxon focuses upon active interaction with users and softwareportability to create powerful, cost effective cross platform solutions andprogramming interfaces to power modern cheminformatics and chemicalcommunication. For more information please visit http://www.chemaxon.com.
Note to Editors: Further technology, corporate citizenship and executivenews is available on the Agilent news site at http://www.agilent.com/go/news.
SOURCE ChemAxon Ltd.